(Ivanhoe Newswire) -- Treating pregnant women for mild gestational
diabetes resulted in fewer cesarean sections and other serious birthing problems
associated with larger than average babies, according to a study conducted in
part at the University of North Carolina, Chapel Hill.
"This study is important because it clearly indicates the value to mothers and
their newborns of screening for and treatment of diabetes-like conditions
provoked by pregnancy," John M. Thorp, M.D., McAllister distinguished professor
of obstetrics and gynecology at the UNC School of Medicine and a co-author of
the study, is quoted as saying. "Our work resolves a 40-year controversy in
women's health and should be immediately helpful to both pregnant women and the
clinicians caring for them."
Close to 4 percent of pregnant women in the U.S. develop gestational diabetes --
about 135,000 cases each year, Thorp said. Because these women have high blood
sugar levels, their babies receive more blood glucose than they need, and the
extra energy is stored as fat. The babies tend to be larger and fatter than
average at birth and thus are more likely to have problems, such as the need for
cesarean delivery, damage to their shoulders during birth and a greater risk of
becoming obese as children and developing type 2 diabetes as adults.
There has been a running controversy among physicians about whether treating
pregnant women for gestational diabetes is worthwhile. Several professional
organizations advocate screening, but the 2008 guidelines of the U.S. Preventive
Services Task Force concluded there is insufficient evidence to support
screening for and treatment of gestational diabetes.
Against this background, the Eunice Kennedy Shriver National Institute of Child
Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network
launched a 14-site clinical trial to determine if treating mothers for mild
gestational diabetes would reduce infant deaths and birth-related complications.
A total of 958 women between 24 and 31 weeks of pregnancy were randomized. Of
these, 485 received treatment that included diet changes, self blood glucose
monitoring and insulin if necessary; 473 were untreated.
There were no infant deaths in the study and no significant differences between
the two groups in terms of babies born with problems such as hypoglycemia,
hyperbilirubinemia, neonatal hyperinsulinemia and birth trauma. However,
significantly fewer babies in the treatment group experienced unusually large
size, high birth weight, shoulder damage during birth or the need for cesarean
delivery.
In addition, said Thorp, "It's especially intriguing that mothers in the
treatment arm gained less weight during pregnancy, experienced fewer preterm
births and had fewer cases of preeclampsia than mothers in the untreated group."
Preeclampsia is a syndrome marked by a sudden increase in the blood pressure of
a pregnant woman after the 20th week of pregnancy, which can be fatal or lead to
long-term health problems for both mother and baby.
The study concluded, "These findings confirm a benefit to the identification and
treatment of women with mild carbohydrate intolerance during pregnancy."
SOURCE: New England Journal of Medicine, October 1, 2009
